About Osimertinib
Class: | Tyrosine kinase inhibitor (TKI)
Use: | Treatment of non-small cell lung cancer (NSCLC) with EGFR mutations, particularly for patients with T790M mutation after progression on prior EGFR TKI therapy
Adult dose: | 80 mg orally once daily
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children
Side effects: | Diarrhea, rash, dry skin, nausea, fatigue, decreased appetite, and interstitial lung disease
Contraindications: | Hy
Drug Class
Tyrosine kinase inhibitor (TKI)
Uses & Indications
Treatment of non-small cell lung cancer (NSCLC) with EGFR mutations, particularly for patients with T790M mutation after progression on prior EGFR TKI therapy
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: AstraZeneca AB, SWEDEN
Package Size
30's (10's Blister x 3)
Price & Supplier
Price in UAE: AED 40131.00
Dosage Information
Adult Dose
80 mg orally once daily
Pediatric Dose
Safety and efficacy not established in pediatric patients; not recommended for use in children
Side Effects
Diarrhea, rash, dry skin, nausea, fatigue, decreased appetite, and interstitial lung disease
Contraindications & Precautions
Hypersensitivity to osimertinib or any component of the formulation; caution in patients with a history of interstitial lung disease
Important Warnings
Risk of serious adverse reactions including interstitial lung disease, QT prolongation, and hepatotoxicity; monitor for signs of lung disease and liver function during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.